Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Alan

Showing results (241-250 of 382) with videos related to

Pageof 39
Sort By:
Clinical Epidemiology|June 9, 2022
Lipid Testing Trends Before and After Hospitalization for Myocardial Infarction Among Adults in the United States, 2008-2019Sara N Levintow, Stephanie R Reading, Sina Noshad, et al.
Circulation|April 8, 2009
Statin adherence and risk of accidents: a cautionary taleColin R Dormuth, Amanda R Patrick, William H Shrank, et al.
Medical Care|October 25, 2007
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial resultsSebastian Schneeweiss, Amanda R Patrick, Til Stürmer, et al.
Journal of the American Society of Nephrology : JASN|April 4, 2008
The effect of altitude on dosing and response to erythropoietin in ESRDM Alan Brookhart, Sebastian Schneeweiss, Jerry Avorn, et al.
Plos One|February 16, 2017
Correction: Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis-A Meta-AnalysisAnat Fisher, Ken Bassett, Gautam Goel, et al.
American Journal of Epidemiology|March 10, 2023
A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in ChildrenDwight E Yin, Stephen R Cole, Christina Ludema, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2)M Alan Menter, Nehal N Mehta, Mark G Lebwohl, et al.
The Journal of Rheumatology|December 7, 2007
Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004Suzanne M Cadarette, Jeffrey N Katz, M Alan Brookhart, et al.
Pharmacoepidemiology and Drug Safety|August 19, 2022
Visualizations throughout pharmacoepidemiology study planning, implementation, and reportingNicolle M Gatto, Shirley V Wang, William Murk, et al.
JSES International|January 17, 2025
Can Patient-Reported Outcomes Measurement Information System estimate high-impact chronic pain after total shoulder arthroplasty?Katherine S Norman, M Alan Brookhart, Oke Anakwenze, et al.
Pageof 39

Showing results (241-250 of 382) with videos related to

Sort By:
Pageof 39
Clinical Epidemiology|June 9, 2022
Lipid Testing Trends Before and After Hospitalization for Myocardial Infarction Among Adults in the United States, 2008-2019Sara N Levintow, Stephanie R Reading, Sina Noshad, et al.
Circulation|April 8, 2009
Statin adherence and risk of accidents: a cautionary taleColin R Dormuth, Amanda R Patrick, William H Shrank, et al.
Medical Care|October 25, 2007
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial resultsSebastian Schneeweiss, Amanda R Patrick, Til Stürmer, et al.
Journal of the American Society of Nephrology : JASN|April 4, 2008
The effect of altitude on dosing and response to erythropoietin in ESRDM Alan Brookhart, Sebastian Schneeweiss, Jerry Avorn, et al.
Plos One|February 16, 2017
Correction: Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis-A Meta-AnalysisAnat Fisher, Ken Bassett, Gautam Goel, et al.
American Journal of Epidemiology|March 10, 2023
A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in ChildrenDwight E Yin, Stephen R Cole, Christina Ludema, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2)M Alan Menter, Nehal N Mehta, Mark G Lebwohl, et al.
The Journal of Rheumatology|December 7, 2007
Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004Suzanne M Cadarette, Jeffrey N Katz, M Alan Brookhart, et al.
Pharmacoepidemiology and Drug Safety|August 19, 2022
Visualizations throughout pharmacoepidemiology study planning, implementation, and reportingNicolle M Gatto, Shirley V Wang, William Murk, et al.
JSES International|January 17, 2025
Can Patient-Reported Outcomes Measurement Information System estimate high-impact chronic pain after total shoulder arthroplasty?Katherine S Norman, M Alan Brookhart, Oke Anakwenze, et al.
Pageof 39